3-(6-fluorobenzothiazol-2-yl)-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine → HCID 67521374, compound

HRID 1926383Notes

Reaction equation

HRID 1926383 reaction equation
F[C:2]1[CH:28]=[CH:27][C:5]2[N:6]=[C:7]([C:9]3[C:10]([NH2:26])=[N:11][CH:12]=[C:13]([C:15]4[CH:16]=[N:17][N:18]([CH:20]5[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]5)[CH:19]=4)[CH:14]=3)[S:8][C:4]=2[CH:3]=1.I[C:30]1SC2C=CC=C(C)C=2N=1>>[CH3:30][C:27]1[C:5]2[N:6]=[C:7]([C:9]3[C:10]([NH2:26])=[N:11][CH:12]=[C:13]([C:15]4[CH:16]=[N:17][N:18]([CH:20]5[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]5)[CH:19]=4)[CH:14]=3)[S:8][C:4]=2[CH:3]=[CH:2][CH:28]=1

Participants

3

Reactant 2

HCID 675210153-(6-fluorobenzothiazol-2-yl)-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamineHCID 67521502HCID 67521502, compound

Product 1

HCID 67521374HCID 67521374, compound

Procedure

Same procedure as 3-(6-fluorobenzothiazol-2-yl)-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine except using 2-iodo-4-methyl-1,3-benzothiazole in place of 2-chloro-6-fluorobenzothiazole to afford the title compound as a yellow solid. 1H NMR (400 MHz, DMSO-d6): δ=2.10-2.31 (m, 4H), 2.74 (s, 3H), 3.05-3.18 (m, 2H), 3.41 (d, J=13.2 Hz, 2H), 4.49-4.57 (m, 1H), 7.41-7.48 (m, 2H), 8.02 (dd, J=6.4, 2.7 Hz, 1H), 8.09 (s, 1H), 8.45 (s, 1H), 8.49 (br. s., 1H), 8.56 (d, J=1.8 Hz, 1H). MS (ES+): m/z=391.14 [MH+]. HPLC: tR=2.11 min (ZQ2, polar—5 min).

Sources & evidence

ORD record
ord-7f1e9140824746a9bbbd84de79ed995a
Source dataset
uspto-grants-2012_05
Patent number
US08178668B2

Reaction notes

Loading…